Highlights

array(40) {
  [0]=>
  string(4) "2027"
  ["article_id"]=>
  string(4) "2027"
  [1]=>
  string(54) "FDA Issues Final Guidance on Bench Performance Testing"
  ["article_title"]=>
  string(54) "FDA Issues Final Guidance on Bench Performance Testing"
  [2]=>
  string(153) "&#nl        The FDA issued final guidance recommending what information devicemakers should include in test report summaries, test protocols and complete"
  ["short_description"]=>
  string(153) "&#nl        The FDA issued final guidance recommending what information devicemakers should include in test report summaries, test protocols and complete"
  [3]=>
  string(252) "&#nl        The FDA issued final guidance recommending what information devicemakers should include in test report summaries, test protocols and complete rest reports for non-clinical bench performance testing for their premarket submissions.&#nl      "
  ["description"]=>
  string(252) "&#nl        The FDA issued final guidance recommending what information devicemakers should include in test report summaries, test protocols and complete rest reports for non-clinical bench performance testing for their premarket submissions.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "19"
  ["rss_id"]=>
  string(2) "19"
  [14]=>
  string(94) "https://www.fdanews.com/articles/191171-fda-issues-final-guidance-on-bench-performance-testing"
  ["blog_url"]=>
  string(94) "https://www.fdanews.com/articles/191171-fda-issues-final-guidance-on-bench-performance-testing"
  [15]=>
  string(19) "2019-05-04 04:49:00"
  ["add_date"]=>
  string(19) "2019-05-04 04:49:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:59"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

FDA Issues Final Guidance on Bench Performance Testing

&#nl The FDA issued final guidance recommending what information devicemakers should include in test report summa

array(40) {
  [0]=>
  string(4) "2028"
  ["article_id"]=>
  string(4) "2028"
  [1]=>
  string(63) "FDA Addresses Safety Concerns for Surgical Staplers and Staples"
  ["article_title"]=>
  string(63) "FDA Addresses Safety Concerns for Surgical Staplers and Staples"
  [2]=>
  string(153) "&#nl        The FDA issued a draft guidance and proposed order designed to ensure the safe and effective use of surgical staplers and staples for interna"
  ["short_description"]=>
  string(153) "&#nl        The FDA issued a draft guidance and proposed order designed to ensure the safe and effective use of surgical staplers and staples for interna"
  [3]=>
  string(169) "&#nl        The FDA issued a draft guidance and proposed order designed to ensure the safe and effective use of surgical staplers and staples for internal use.&#nl      "
  ["description"]=>
  string(169) "&#nl        The FDA issued a draft guidance and proposed order designed to ensure the safe and effective use of surgical staplers and staples for internal use.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "19"
  ["rss_id"]=>
  string(2) "19"
  [14]=>
  string(103) "https://www.fdanews.com/articles/191166-fda-addresses-safety-concerns-for-surgical-staplers-and-staples"
  ["blog_url"]=>
  string(103) "https://www.fdanews.com/articles/191166-fda-addresses-safety-concerns-for-surgical-staplers-and-staples"
  [15]=>
  string(19) "2019-05-04 04:42:12"
  ["add_date"]=>
  string(19) "2019-05-04 04:42:12"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:59"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

FDA Addresses Safety Concerns for Surgical Staplers and Staples

&#nl The FDA issued a draft guidance and proposed order designed to ensure the safe and effective use of surgical

array(40) {
  [0]=>
  string(4) "2029"
  ["article_id"]=>
  string(4) "2029"
  [1]=>
  string(68) "European Commission Releases Details on Eudamed, Nomenclature System"
  ["article_title"]=>
  string(68) "European Commission Releases Details on Eudamed, Nomenclature System"
  [2]=>
  string(153) "&#nl        The European Commission released long-awaited guidance on Eudamed (the European Database on Medical Devices) and the device nomenclature syst"
  ["short_description"]=>
  string(153) "&#nl        The European Commission released long-awaited guidance on Eudamed (the European Database on Medical Devices) and the device nomenclature syst"
  [3]=>
  string(259) "&#nl        The European Commission released long-awaited guidance on Eudamed (the European Database on Medical Devices) and the device nomenclature system that will be used for the EU’s new medical device and in vitro diagnostic regulations.&#nl      "
  ["description"]=>
  string(259) "&#nl        The European Commission released long-awaited guidance on Eudamed (the European Database on Medical Devices) and the device nomenclature system that will be used for the EU’s new medical device and in vitro diagnostic regulations.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "19"
  ["rss_id"]=>
  string(2) "19"
  [14]=>
  string(107) "https://www.fdanews.com/articles/191165-european-commission-releases-details-on-eudamed-nomenclature-system"
  ["blog_url"]=>
  string(107) "https://www.fdanews.com/articles/191165-european-commission-releases-details-on-eudamed-nomenclature-system"
  [15]=>
  string(19) "2019-05-04 04:40:54"
  ["add_date"]=>
  string(19) "2019-05-04 04:40:54"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:59"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

European Commission Releases Details on Eudamed, Nomenclature System

&#nl The European Commission released long-awaited guidance on Eudamed (the European Database on Medical Devices)

array(40) {
  [0]=>
  string(4) "2030"
  ["article_id"]=>
  string(4) "2030"
  [1]=>
  string(87) "FDA Warns Boston’s TEI Biosciences Over ‘Systemic’ Quality Failures"
  ["article_title"]=>
  string(87) "FDA Warns Boston’s TEI Biosciences Over ‘Systemic’ Quality Failures"
  [2]=>
  string(166) "&#nl        The FDA issued a warning letter to TEI Biosciences’ for “systemic” quality failures the agency found during an Oct. 9 to Nov. 2, 2018, "
  ["short_description"]=>
  string(166) "&#nl        The FDA issued a warning letter to TEI Biosciences’ for “systemic” quality failures the agency found during an Oct. 9 to Nov. 2, 2018, "
  [3]=>
  string(219) "&#nl        The FDA issued a warning letter to TEI Biosciences’ for “systemic” quality failures the agency found during an Oct. 9 to Nov. 2, 2018, inspection of its Boston, Mass., facility. &#nl      "
  ["description"]=>
  string(219) "&#nl        The FDA issued a warning letter to TEI Biosciences’ for “systemic” quality failures the agency found during an Oct. 9 to Nov. 2, 2018, inspection of its Boston, Mass., facility. &#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "19"
  ["rss_id"]=>
  string(2) "19"
  [14]=>
  string(104) "https://www.fdanews.com/articles/191163-fda-warns-bostons-tei-biosciences-over-systemic-quality-failures"
  ["blog_url"]=>
  string(104) "https://www.fdanews.com/articles/191163-fda-warns-bostons-tei-biosciences-over-systemic-quality-failures"
  [15]=>
  string(19) "2019-05-04 04:34:09"
  ["add_date"]=>
  string(19) "2019-05-04 04:34:09"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:59"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

FDA Warns Boston’s TEI Biosciences Over ‘Systemic’ Quality Failures

&#nl The FDA issued a warning letter to TEI Biosciences’ for “systemic” quality failures the a

array(40) {
  [0]=>
  string(4) "2031"
  ["article_id"]=>
  string(4) "2031"
  [1]=>
  string(60) "NEMA Issues New QMS Standard for Servicing Imaging Equipment"
  ["article_title"]=>
  string(60) "NEMA Issues New QMS Standard for Servicing Imaging Equipment"
  [2]=>
  string(156) "&#nl        The National Electrical Manufacturers Association (NEMA) released a new quality management standard for servicing medical imaging equipmentâ€"
  ["short_description"]=>
  string(156) "&#nl        The National Electrical Manufacturers Association (NEMA) released a new quality management standard for servicing medical imaging equipmentâ€"
  [3]=>
  string(265) "&#nl        The National Electrical Manufacturers Association (NEMA) released a new quality management standard for servicing medical imaging equipment—designed to ensure equipment is returned to a safe and effective condition for its intended use.&#nl      "
  ["description"]=>
  string(265) "&#nl        The National Electrical Manufacturers Association (NEMA) released a new quality management standard for servicing medical imaging equipment—designed to ensure equipment is returned to a safe and effective condition for its intended use.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "19"
  ["rss_id"]=>
  string(2) "19"
  [14]=>
  string(100) "https://www.fdanews.com/articles/191161-nema-issues-new-qms-standard-for-servicing-imaging-equipment"
  ["blog_url"]=>
  string(100) "https://www.fdanews.com/articles/191161-nema-issues-new-qms-standard-for-servicing-imaging-equipment"
  [15]=>
  string(19) "2019-05-04 04:16:28"
  ["add_date"]=>
  string(19) "2019-05-04 04:16:28"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:59"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:59"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

NEMA Issues New QMS Standard for Servicing Imaging Equipment

&#nl The National Electrical Manufacturers Association (NEMA) released a new quality management standard for serv

array(40) {
  [0]=>
  string(4) "2200"
  ["article_id"]=>
  string(4) "2200"
  [1]=>
  string(62) "People on the Move: Outsourcing-Pharma roundup April ‘19"
  ["article_title"]=>
  string(62) "People on the Move: Outsourcing-Pharma roundup April ‘19"
  [2]=>
  string(152) "Synteract adds to its therapeutic centers of development, Sterling Pharma continues growth in the US, and WCGâs site division sees the addition of se"
  ["short_description"]=>
  string(152) "Synteract adds to its therapeutic centers of development, Sterling Pharma continues growth in the US, and WCGâs site division sees the addition of se"
  [3]=>
  string(212) "Synteract adds to its therapeutic centers of development, Sterling Pharma continues growth in the US, and WCGâs site division sees the addition of several executives, among other people on the move this month."
  ["description"]=>
  string(212) "Synteract adds to its therapeutic centers of development, Sterling Pharma continues growth in the US, and WCGâs site division sees the addition of several executives, among other people on the move this month."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "49"
  ["rss_id"]=>
  string(2) "49"
  [14]=>
  string(160) "https://www.outsourcing-pharma.com/Article/2019/05/03/People-on-the-Move-Outsourcing-Pharma-roundup-April-19?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(160) "https://www.outsourcing-pharma.com/Article/2019/05/03/People-on-the-Move-Outsourcing-Pharma-roundup-April-19?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2019-05-04 00:58:00"
  ["add_date"]=>
  string(19) "2019-05-04 00:58:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:44"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:44"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

People on the Move: Outsourcing-Pharma roundup April ‘19

Synteract adds to its therapeutic centers of development, Sterling Pharma continues growth in the US, and WCGâs site

array(40) {
  [0]=>
  string(4) "2353"
  ["article_id"]=>
  string(4) "2353"
  [1]=>
  string(50) "&#nlEMA annual report 2018 published, , 03/05/2019"
  ["article_title"]=>
  string(50) "&#nlEMA annual report 2018 published, , 03/05/2019"
  [2]=>
  string(179) "&#nl&#nl          &#nl              The &#nl&#nl&#nl  annual report&#nl&#nlpublished today provides an overview of the Agency’s activities to protect and promote the health"
  ["short_description"]=>
  string(179) "&#nl&#nl          &#nl              The &#nl&#nl&#nl  annual report&#nl&#nlpublished today provides an overview of the Agency’s activities to protect and promote the health"
  [3]=>
  string(214) "&#nl&#nl          &#nl              The &#nl&#nl&#nl  annual report&#nl&#nlpublished today provides an overview of the Agency’s activities to protect and promote the health of people and animals in the EU..."
  ["description"]=>
  string(214) "&#nl&#nl          &#nl              The &#nl&#nl&#nl  annual report&#nl&#nlpublished today provides an overview of the Agency’s activities to protect and promote the health of people and animals in the EU..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "88"
  ["rss_id"]=>
  string(2) "88"
  [14]=>
  string(67) "
https://www.ema.europa.eu/en/news/ema-annual-report-2018-published"
  ["blog_url"]=>
  string(67) "
https://www.ema.europa.eu/en/news/ema-annual-report-2018-published"
  [15]=>
  string(19) "2019-05-03 22:15:00"
  ["add_date"]=>
  string(19) "2019-05-03 22:15:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:42:13"
  ["create_at"]=>
  string(19) "2019-05-09 16:42:13"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

&#nlEMA annual report 2018 published, , 03/05/2019

&#nl&#nl &#nl The &#nl&#nl&#nl annual report&#nl&#nlpublished today provides an overview of the A

array(40) {
  [0]=>
  string(4) "1958"
  ["article_id"]=>
  string(4) "1958"
  [1]=>
  string(74) "Lloyds given £17m contract to run pharmacy services in Scottish prisons"
  ["article_title"]=>
  string(74) "Lloyds given £17m contract to run pharmacy services in Scottish prisons"
  [2]=>
  string(115) "LloydsPharmacy has been awarded a £17m contract to run pharmacy services in all of Scotland’s 15 prisons."
  ["short_description"]=>
  string(115) "LloydsPharmacy has been awarded a £17m contract to run pharmacy services in all of Scotland’s 15 prisons."
  [3]=>
  string(115) "LloydsPharmacy has been awarded a £17m contract to run pharmacy services in all of Scotland’s 15 prisons."
  ["description"]=>
  string(115) "LloydsPharmacy has been awarded a £17m contract to run pharmacy services in all of Scotland’s 15 prisons."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "11"
  ["rss_id"]=>
  string(2) "11"
  [14]=>
  string(158) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/lloyds-given-17m-contract-to-run-pharmacy-services-in-scottish-prisons/20206503.article"
  ["blog_url"]=>
  string(158) "https://www.pharmaceutical-journal.com/news-and-analysis/news-in-brief/lloyds-given-17m-contract-to-run-pharmacy-services-in-scottish-prisons/20206503.article"
  [15]=>
  string(19) "2019-05-03 22:04:00"
  ["add_date"]=>
  string(19) "2019-05-03 22:04:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:53"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Lloyds given £17m contract to run pharmacy services in Scottish prisons

LloydsPharmacy has been awarded a £17m contract to run pharmacy services in all of Scotland’s 15 prisons.

array(40) {
  [0]=>
  string(4) "2102"
  ["article_id"]=>
  string(4) "2102"
  [1]=>
  string(92) "Manufacturer taps into protein snack 'explosion' with multi-million pound investment"
  ["article_title"]=>
  string(92) "Manufacturer taps into protein snack 'explosion' with multi-million pound investment"
  [2]=>
  string(150) "A health supplements and sports nutrition contract manufacturer has made a multi-million pound investment in a new state-of-the-art protein bar and sn"
  ["short_description"]=>
  string(150) "A health supplements and sports nutrition contract manufacturer has made a multi-million pound investment in a new state-of-the-art protein bar and sn"
  [3]=>
  string(177) "A health supplements and sports nutrition contract manufacturer has made a multi-million pound investment in a new state-of-the-art protein bar and snack manufacturing facility."
  ["description"]=>
  string(177) "A health supplements and sports nutrition contract manufacturer has made a multi-million pound investment in a new state-of-the-art protein bar and snack manufacturing facility."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "35"
  ["rss_id"]=>
  string(2) "35"
  [14]=>
  string(186) "https://www.nutraingredients.com/Article/2019/05/03/Manufacturer-taps-into-protein-snack-explosion-with-multi-million-pound-investment?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  ["blog_url"]=>
  string(186) "https://www.nutraingredients.com/Article/2019/05/03/Manufacturer-taps-into-protein-snack-explosion-with-multi-million-pound-investment?utm_source=RSS_Feed&utm_medium=RSS&utm_campaign=RSS"
  [15]=>
  string(19) "2019-05-03 19:28:00"
  ["add_date"]=>
  string(19) "2019-05-03 19:28:00"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:32"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:32"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Manufacturer taps into protein snack 'explosion' with multi-million pound investme

A health supplements and sports nutrition contract manufacturer has made a multi-million pound investment in a new state

array(40) {
  [0]=>
  string(4) "2117"
  ["article_id"]=>
  string(4) "2117"
  [1]=>
  string(69) "Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More"
  ["article_title"]=>
  string(69) "Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More"
  [2]=>
  string(150) "America continues to suffer from healthcare headaches. Our convoluted private-public insurance system was under scrutiny this week from Democrats, hol"
  ["short_description"]=>
  string(150) "America continues to suffer from healthcare headaches. Our convoluted private-public insurance system was under scrutiny this week from Democrats, hol"
  [3]=>
  string(397) "America continues to suffer from healthcare headaches. Our convoluted private-public insurance system was under scrutiny this week from Democrats, holding a “Medicare for All” hearing in the House, and from Republicans, as several GOP-led states and the Trump administration asked a federal court to sweep away Obamacare. Several companies also want to reduce headaches. This […]"
  ["description"]=>
  string(397) "America continues to suffer from healthcare headaches. Our convoluted private-public insurance system was under scrutiny this week from Democrats, holding a “Medicare for All” hearing in the House, and from Republicans, as several GOP-led states and the Trump administration asked a federal court to sweep away Obamacare. Several companies also want to reduce headaches. This […]"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "36"
  ["rss_id"]=>
  string(2) "36"
  [14]=>
  string(105) "https://xconomy.com/national/2019/05/03/bio-roundup-head-and-spine-previews-biogen-moves-ipo-dreams-more/"
  ["blog_url"]=>
  string(105) "https://xconomy.com/national/2019/05/03/bio-roundup-head-and-spine-previews-biogen-moves-ipo-dreams-more/"
  [15]=>
  string(19) "2019-05-03 19:00:11"
  ["add_date"]=>
  string(19) "2019-05-03 19:00:11"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:33"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:33"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Bio Roundup: Head and Spine Previews, Biogen Moves, IPO Dreams & More

America continues to suffer from healthcare headaches. Our convoluted private-public insurance system was under scrutiny

array(40) {
  [0]=>
  string(4) "2186"
  ["article_id"]=>
  string(4) "2186"
  [1]=>
  string(59) "Sandoz enters agreement for proposed trastuzumab biosimilar"
  ["article_title"]=>
  string(59) "Sandoz enters agreement for proposed trastuzumab biosimilar"
  [2]=>
  string(150) "Sandoz, a Novartis division, announced that it has entered into an agreement to commercialize a proposed trastuzumab biosimilar. This medicine is curr"
  ["short_description"]=>
  string(150) "Sandoz, a Novartis division, announced that it has entered into an agreement to commercialize a proposed trastuzumab biosimilar. This medicine is curr"
  [3]=>
  string(725) "Sandoz, a Novartis division, announced that it has entered into an agreement to commercialize a proposed trastuzumab biosimilar. This medicine is currently in Phase III clinical development for treatment of human epidermal growth factor receptor 2 positive (HER2+) breast and specific gastric cancer tumors. The agreement between Sandoz and EirGenix, Inc, a biotechnology manufacturing and development company that aspires to provide high-quality medicines for individuals and society, aims to bring to market a proposed biosimilar trastuzumab. EirGenix will maintain responsibility […]""/"
  ["description"]=>
  string(725) "Sandoz, a Novartis division, announced that it has entered into an agreement to commercialize a proposed trastuzumab biosimilar. This medicine is currently in Phase III clinical development for treatment of human epidermal growth factor receptor 2 positive (HER2+) breast and specific gastric cancer tumors. The agreement between Sandoz and EirGenix, Inc, a biotechnology manufacturing and development company that aspires to provide high-quality medicines for individuals and society, aims to bring to market a proposed biosimilar trastuzumab. EirGenix will maintain responsibility […]""/"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "43"
  ["rss_id"]=>
  string(2) "43"
  [14]=>
  string(61) "http://feedproxy.google.com/~r/BiosimilarNews/~3/iFBZRNtAraY/"
  ["blog_url"]=>
  string(61) "http://feedproxy.google.com/~r/BiosimilarNews/~3/iFBZRNtAraY/"
  [15]=>
  string(19) "2019-05-03 17:59:28"
  ["add_date"]=>
  string(19) "2019-05-03 17:59:28"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:41:41"
  ["create_at"]=>
  string(19) "2019-05-09 16:41:41"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

Sandoz enters agreement for proposed trastuzumab biosimilar

Sandoz, a Novartis division, announced that it has entered into an agreement to commercialize a proposed trastuzumab bio

array(40) {
  [0]=>
  string(4) "1870"
  ["article_id"]=>
  string(4) "1870"
  [1]=>
  string(72) "NHS improvements to give patients faster access to pioneering treatments"
  ["article_title"]=>
  string(72) "NHS improvements to give patients faster access to pioneering treatments"
  [2]=>
  string(150) "New improvements to the Accelerated Access Collaborative (AAC) will put the most promising medicines through the clinical development and regulatory a"
  ["short_description"]=>
  string(150) "New improvements to the Accelerated Access Collaborative (AAC) will put the most promising medicines through the clinical development and regulatory a"
  [3]=>
  string(173) "New improvements to the Accelerated Access Collaborative (AAC) will put the most promising medicines through the clinical development and regulatory approval process faster."
  ["description"]=>
  string(173) "New improvements to the Accelerated Access Collaborative (AAC) will put the most promising medicines through the clinical development and regulatory approval process faster."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(1) "4"
  ["rss_id"]=>
  string(1) "4"
  [14]=>
  string(112) "http://www.pharmatimes.com/news/nhs_improvements_to_give_patients_faster_access_to_pioneering_treatments_1286625"
  ["blog_url"]=>
  string(112) "http://www.pharmatimes.com/news/nhs_improvements_to_give_patients_faster_access_to_pioneering_treatments_1286625"
  [15]=>
  string(19) "2019-05-03 17:53:16"
  ["add_date"]=>
  string(19) "2019-05-03 17:53:16"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2019-05-09 16:35:49"
  ["create_at"]=>
  string(19) "2019-05-09 16:35:49"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

NHS improvements to give patients faster access to pioneering treatments

New improvements to the Accelerated Access Collaborative (AAC) will put the most promising medicines through the clinica